Clinical Outcomes of High-dose-rate Brachytherapy and External Beam Radiotherapy in the Management of Clinically Localized Prostate Cancer

Rupesh Kotecha; Yoshiya Yamada; Xin Pei; Marisa A. Kollmeier; Brett Cox; Gil'ad N. Cohen; Marco Zaider; Michael J. Zelefsky

doi:10.1016/j.brachy.2012.05.003

Clinical Outcomes of High-dose-rate Brachytherapy and External Beam Radiotherapy in the Management of Clinically Localized Prostate Cancer

Rupesh Kotecha, Yoshiya Yamada, Xin Pei, Marisa A. Kollmeier, Brett Cox, Gil'ad N. Cohen, Marco Zaider, Michael J. Zelefsky

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Brachytherapy
Volume	12
DOIs	https://doi.org/10.1016/j.brachy.2012.05.003
State	Published - Jan 1 2013

Disciplines

Radiology
Medicine and Health Sciences
Obstetrics and Gynecology
Oncology
Medical Biophysics

Access to Document

10.1016/j.brachy.2012.05.003License: Unspecified

Cite this

@article{beb8d1cc10014afdae9ff9f0d0fe9a04,

title = "Clinical Outcomes of High-dose-rate Brachytherapy and External Beam Radiotherapy in the Management of Clinically Localized Prostate Cancer",

author = "Rupesh Kotecha and Yoshiya Yamada and Xin Pei and Kollmeier, {Marisa A.} and Brett Cox and Cohen, {Gil'ad N.} and Marco Zaider and Zelefsky, {Michael J.}",

note = "Purpose: To report prostate-specific antigen (PSA) relapse-free survival and treatment-related toxicity outcomes after combining high-dose-rate (HDR) brachytherapy with external beam radiotherapy (EBRT) for patients with clinically localized prostate cancer. Methods and materials: Between 1998 and 2009, 229 patients were treated with HDR brachytherapy followed 3 weeks later by supplemental EBRT.",

year = "2013",

month = jan,

day = "1",

doi = "10.1016/j.brachy.2012.05.003",

language = "American English",

volume = "12",

journal = "Brachytherapy",

}

TY - JOUR

T1 - Clinical Outcomes of High-dose-rate Brachytherapy and External Beam Radiotherapy in the Management of Clinically Localized Prostate Cancer

AU - Kotecha, Rupesh

AU - Yamada, Yoshiya

AU - Pei, Xin

AU - Kollmeier, Marisa A.

AU - Cox, Brett

AU - Cohen, Gil'ad N.

AU - Zaider, Marco

AU - Zelefsky, Michael J.

N1 - Purpose: To report prostate-specific antigen (PSA) relapse-free survival and treatment-related toxicity outcomes after combining high-dose-rate (HDR) brachytherapy with external beam radiotherapy (EBRT) for patients with clinically localized prostate cancer. Methods and materials: Between 1998 and 2009, 229 patients were treated with HDR brachytherapy followed 3 weeks later by supplemental EBRT.

PY - 2013/1/1

Y1 - 2013/1/1

UR - https://pubmed.ncbi.nlm.nih.gov/22831750/

U2 - 10.1016/j.brachy.2012.05.003

DO - 10.1016/j.brachy.2012.05.003

M3 - Article

VL - 12

JO - Brachytherapy

JF - Brachytherapy

ER -

Clinical Outcomes of High-dose-rate Brachytherapy and External Beam Radiotherapy in the Management of Clinically Localized Prostate Cancer

Disciplines

Access to Document

Other files and links

Cite this